Trial: 202003066

Evaluation of Vigamox Treatment for Ocular Graft-Versus-Host Disease

Phase

II

Principal Investigator

Margolis, Todd

Disease Site

Hodgkin Lymphoma; Leukemia, other; Lymphoid Leukemia; Multiple Myeloma; Myeloid and Monocytic Leukemia; Non-Hodgkin Lymphoma; Other Hematopoietic

Learn more about this study at: clinicaltrials.gov